Jump to navigation Jump to search
|Chemical and physical data|
|Molar mass||143.6 kg/mol g·mol−1|
|(what is this?)|
Development was discontinued in 2015.
- Statement on a Nonproprietary Name adopted by the USAN Council - Lexatumumab, American Medical Association.
- "Archived copy". Archived from the original on 2008-05-16. Retrieved 2010-05-12.CS1 maint: Archived copy as title (link)
- "Lexatumumab - AdisInsight". adisinsight.springer.com.
|This monoclonal antibody–related article is a stub. You can help Wikipedia by expanding it.|
|This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it.|